Working to Eradicate Gynecologic Cancers

41 - Featured Poster
The impact and interaction of preoperative disease burden, complex surgery, and residual disease in patients with advanced stage ovarian cancer and the effect on on patient survival: A GOG 182 analysis

Sunday, March 23, 2014: 6:35 AM
Room 13-16 (Tampa Convention Center)
T. C. Krivak1, A. Miller2, B. J. Rungruang3, N. S. Horowitz4, S. D. Richard5, N. Rodriguez6, M. A. Bookman7, C. A. Hamilton8 and G. L. Maxwell9
1Western Pennsylvania Hospital, Pittsburgh, PA, 2Gynecologic Oncology Group, Buffalo, NY, 3Georgia Reagents University, Evans, GA, 4Harvard University, Boston, MA, 5Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, PA, 6Loma Linda University Medical Center, Loma Linda, CA, 7University of Arizona Cancer Center, Tucson, AZ, 8Walter Reed National Military Medical Center, Bethesda, MD, 9Inova Fairfax Hospital, Falls Church, VA